Page last updated: 2024-09-04

carbapenems and fropenem

carbapenems has been researched along with fropenem in 13 studies

Compound Research Comparison

Studies
(carbapenems)
Trials
(carbapenems)
Recent Studies (post-2010)
(carbapenems)
Studies
(fropenem)
Trials
(fropenem)
Recent Studies (post-2010) (fropenem)
7,3551475,2771401352

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (7.69)18.2507
2000's4 (30.77)29.6817
2010's5 (38.46)24.3611
2020's3 (23.08)2.80

Authors

AuthorsStudies
Hikida, M; Igarashi, A; Itahashi, K; Kitamura, M; Shiba, T1
Nishino, T; Oh, T; Okuda, J; Otsuki, M1
Gotoh, N; Nishino, T; Okamoto, K1
Cars, O; Gustafsson, I1
Appelbaum, PC; Glupczynski, Y; Lemaire, S; Olivier, A; Tulkens, PM; Van Bambeke, F1
Barszcz, B; Cielecka-Piontek, J; Lewandowska, K; Paczkowska, M1
Carlson, EE; Kocaoglu, O; Tsui, HC; Winkler, ME1
Kaushik, A; Lamichhane, G; Makkar, N; Pandey, P; Parrish, N; Singh, U1
Schneider, G; Schnell, R; Steiner, EM1
Fukushima, Y; Hiyama, Y; Masumori, N; Nakajima, C; Sato, T; Shinagawa, M; Suzuki, Y; Takahashi, S; Yokota, SI1
Choi, J; Dantas, G; Das, S; Gandra, S; Green, SJ; Harazin, M; McElvania, E; Singh, KS; Thomson, RB1
Chandy, SJ; Dharmapalan, D1
Bouvier, M; Le Terrier, C; Nordmann, P; Poirel, L1

Other Studies

13 other study(ies) available for carbapenems and fropenem

ArticleYear
In vitro antibacterial activity of LJC 11,036, an active metabolite of L-084, a new oral carbapenem antibiotic with potent antipneumococcal activity.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:8

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Carrier Proteins; Cefdinir; Cephalosporins; Dipeptidases; Drug Stability; Escherichia coli Proteins; Hexosyltransferases; Imipenem; Lactams; Levofloxacin; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Ofloxacin; Penicillin-Binding Proteins; Peptidoglycan Glycosyltransferase; Peptidyl Transferases; Protein Binding; Serine-Type D-Ala-D-Ala Carboxypeptidase; Thienamycins

1999
In vitro activity of DU-6681a, an active form of the new oral carbapenem compound DZ-2640, in comparison with that of R-95867, faropenem and oral cephalosporins.
    The Journal of antimicrobial chemotherapy, 2000, Volume: 46, Issue:1

    Topics: Administration, Oral; Anti-Bacterial Agents; Bacteria; beta-Lactams; Carbapenems; Cephalosporins; Lactams; Microbial Sensitivity Tests

2000
Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics: penem resistance mechanisms and their interplay.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:7

    Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Biological Transport; Carbapenems; Carrier Proteins; Escherichia coli; Humans; Lactams; Membrane Transport Proteins; Microbial Sensitivity Tests; Porins; Pseudomonas aeruginosa

2001
The influence of protein binding on the antibacterial activity of faropenem against Haemophilus influenzae.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2004, Volume: 10, Issue:10

    Topics: beta-Lactamases; beta-Lactams; Carbapenems; Colony Count, Microbial; Haemophilus Infections; Haemophilus influenzae; Humans; Lactams; Microbial Sensitivity Tests; Protein Binding; Serum Albumin; Serum Bactericidal Test

2004
Restoration of susceptibility of intracellular methicillin-resistant Staphylococcus aureus to beta-lactams: comparison of strains, cells, and antibiotics.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefepime; Cefuroxime; Cell Line; Cells, Cultured; Cephalosporins; Cloxacillin; Humans; Hydrogen-Ion Concentration; Imipenem; Meropenem; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Phagocytosis; Staphylococcus aureus; Thienamycins

2008
The use of UV, FT-IR and Raman spectra for the identification of the newest penem analogs: solutions based on mathematic procedure and the density functional theory.
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2013, Feb-15, Volume: 103

    Topics: beta-Lactams; Carbapenems; Doripenem; Models, Molecular; Quantum Theory; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Thienamycins

2013
Profiling of β-lactam selectivity for penicillin-binding proteins in Streptococcus pneumoniae D39.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:6

    Topics: Amdinocillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cephalosporins; Doripenem; Electrophoresis, Polyacrylamide Gel; Meropenem; Penicillin-Binding Proteins; Streptococcus pneumoniae; Thienamycins

2015
Carbapenems and Rifampin Exhibit Synergy against Mycobacterium tuberculosis and Mycobacterium abscessus.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:10

    Topics: Antitubercular Agents; beta-Lactams; Carbapenems; Doripenem; Drug Synergism; Meropenem; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium tuberculosis; Rifampin; Thienamycins

2015
Binding and processing of β-lactam antibiotics by the transpeptidase Ldt
    The FEBS journal, 2017, Volume: 284, Issue:5

    Topics: beta-Lactams; Carbapenems; Crystallography, X-Ray; Kinetics; Mycobacterium tuberculosis; Peptidoglycan; Peptidyl Transferases; Protein Conformation; Tuberculosis

2017
Evaluation of Susceptibilities to Carbapenems and Faropenem Against Cephalosporin-Resistant Neisseria gonorrhoeae Clinical Isolates with penA Mosaic Alleles.
    Microbial drug resistance (Larchmont, N.Y.), 2019, Volume: 25, Issue:3

    Topics: Alleles; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Carbapenems; Cephalosporin Resistance; Cephalosporins; Humans; Male; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae

2019
Faropenem resistance causes in vitro cross-resistance to carbapenems in ESBL-producing Escherichia coli.
    International journal of antimicrobial agents, 2020, Volume: 55, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Porins

2020
Oral Faropenem Sodium - Implications for Antimicrobial Resistance and Treatment Effectiveness.
    Indian pediatrics, 2022, 11-15, Volume: 59, Issue:11

    Topics: Anti-Bacterial Agents; Carbapenems; Child; Drug Resistance, Bacterial; Humans; Sodium; Treatment Outcome

2022
Impact of acquired broad-spectrum β-lactamases on susceptibility to oral penems/carbapenems (tebipenem, sulopenem, and faropenem) alone or in combination with avibactam and taniborbactam β-lactamase inhibitors in
    Antimicrobial agents and chemotherapy, 2023, 10-18, Volume: 67, Issue:10

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Escherichia coli; Meropenem; Microbial Sensitivity Tests

2023